Covestor’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Other funds holding JANX
Covestor's JANX Position: Q3 2026 in Review
Covestor reduced its Janux Therapeutics (JANX) stake by 41% in Q3 2026, selling an estimated $202 and leaving 17 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2599.
Covestor first reported a position in JANX in Q2 2024 and has held it in 10 quarters since. 139 funds tracked by Wall St. Rank hold JANX as of Q3 2026.
- Covestor held 17 shares of Janux Therapeutics worth $0 as of Q3 2026.
- Covestor sold 12 Janux Therapeutics shares in Q3 2026, an estimated $202.
- Janux Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2599 holding.
- Covestor first reported a position in Janux Therapeutics in Q2 2024 and has held it in 10 quarters since.
- 139 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.